Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and Cardiac Remodeling, Ventricular

resveratrol has been researched along with Cardiac Remodeling, Ventricular in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (13.64)29.6817
2010's13 (59.09)24.3611
2020's6 (27.27)2.80

Authors

AuthorsStudies
Bu, P; Hai, J; Hu, Y; Kong, B; Ma, X; Ti, Y; Yang, Y; Zhang, C; Zhao, Y; Zheng, X1
Jojima, K; Node, K; Tanaka, A1
Chen, K; Chen, X; Guo, N; Huang, X; Li, P; Liu, Y; Song, X; Wu, C; Yuan, L; Zhang, D1
Acuña-Morín, E; Bernal-Ramírez, J; Chapoy-Villanueva, H; García-Rivas, G; Jerjes-Sánchez, C; Lozano, O; Pérez-Plata, L; Ramírez-Rivera, A; Ramos-González, MR; Sánchez-Trujillo, L; Torre-Amione, G; Vanoye-Tamez, M; Vázquez-Garza, E1
An, J; Feng, L; Li, G; Li, J; Li, Y; Liu, J; Qi, Z; Ren, J; Yang, L; Zhang, S1
Netticadan, T; Parikh, M; Raj, P; Sayfee, K; Wigle, J; Yu, L; Zieroth, S1
Bartolomucci, A; Beker, DL; Dyck, JRB; Grant, MK; Hamza, SM; Matsumura, N; Parajuli, N; Razzoli, M; Robertson, IM; Soltys, CM; Zordoky, BN1
Cui, H; Cui, SY; Fan, L; Hu, YX; Liu, L; Pan, XJ; Shi, SZ; Wei, ZM; Wu, JH1
Hu, CP; Li, TB; Liu, B; Luo, XJ; Ma, QL; Peng, J; Yang, ZB; Zhang, GG; Zhang, JJ; Zhang, XJ1
Abd-Elaziz, HR; Arafa, MH; Atteia, HH; Mohammad, NS1
Boisvenue, J; Byrne, NJ; Das, SK; Dyck, JR; Fung, D; Kim, TT; Levasseur, J; Masson, G; Oudit, GY; Soltys, CL; Sung, MM1
Otis, JS; Rogers, RG1
Ahmet, I; Lakatta, EG; Tae, HJ; Talan, M1
Chih, CL; Hu, BR; Huang, SS; Lin, JF; Lin, SM; Nien, MW; Su, HH; Tsai, SK1
Cai, J; Chen, L; Chen, YR; Li, XY; Su, PX; Wang, CY; Yang, XC; Yi, FF1
Brown, L; Chan, V; Fenning, A; Hoey, A; Iyer, A1
Huang, SS; Lin, JF; Lin, SM; Lu, BY; Tsai, SK; Wu, S1
Berni, R; Bocchi, L; Calani, L; Cavalli, S; Chaponnier, C; Del Rio, D; Delucchi, F; Frati, C; Gabbiani, G; Graiani, G; Lagrasta, C; Quaini, F; Sala, R; Stilli, D1
Anderson, T; Campen, MJ; Candelaria, G; Hesterman, J; Hoppin, J; Irwin, D; Lucas, S; Norenberg, J; Paffett, ML1
Bin, J; Chen, B; Chen, C; Liao, Y; Wu, B; Xu, D; Xuan, W; Zhang, W1
Fujiwara, H; Fujiwara, T; Goto, K; Kanamori, H; Kawaguchi, T; Kawasaki, M; Mikami, A; Minatoguchi, S; Morishita, K; Ogino, A; Seishima, M; Takemura, G; Takeyama, T; Tsujimoto, A; Watanabe, T1
Burstein, B; Calderone, A; Clément, R; Ethier, N; Gosselin, H; Hébert, TE; Maguy, A; Nattel, S; Poulin, F; Tardif, JC1

Trials

1 trial(s) available for resveratrol and Cardiac Remodeling, Ventricular

ArticleYear
Effects of resveratrol supplementation on cardiac remodeling in hypertensive patients: a randomized controlled clinical trial.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2023, Volume: 46, Issue:6

    Topics: Ankle Brachial Index; Dietary Supplements; Fibrosis; Humans; Hypertension; Pulse Wave Analysis; Resveratrol; Ventricular Function, Left; Ventricular Remodeling

2023

Other Studies

21 other study(ies) available for resveratrol and Cardiac Remodeling, Ventricular

ArticleYear
Resveratrol supplementation: a therapeutic potential for cardiac remodeling in hypertensive heart disease.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2023, Volume: 46, Issue:6

    Topics: Dietary Supplements; Heart Diseases; Humans; Hypertension; Resveratrol; Ventricular Remodeling

2023
Resveratrol improves left ventricular remodeling in chronic kidney disease via Sirt1-mediated regulation of FoxO1 activity and MnSOD expression.
    BioFactors (Oxford, England), 2020, Volume: 46, Issue:1

    Topics: Animals; Antioxidants; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Resveratrol; Sirtuin 1; Superoxide Dismutase; Ventricular Remodeling

2020
Resveratrol Prevents Right Ventricle Remodeling and Dysfunction in Monocrotaline-Induced Pulmonary Arterial Hypertension with a Limited Improvement in the Lung Vasculature.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Animals; Antioxidants; Disease Models, Animal; Echocardiography; Lung; Male; Pulmonary Arterial Hypertension; Rats; Rats, Sprague-Dawley; Resveratrol; Ventricular Remodeling

2020
Resveratrol prevents ISO-induced myocardial remodeling associated with regulating polarization of macrophages through VEGF-B/AMPK/NF-kB pathway.
    International immunopharmacology, 2020, Volume: 84

    Topics: AMP-Activated Protein Kinases; Animals; Cytokines; Isoproterenol; Macrophages; Male; Mice; Mice, Inbred BALB C; Myocardium; NF-kappa B; RAW 264.7 Cells; Resveratrol; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factor B; Ventricular Remodeling

2020
Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats.
    Molecules (Basel, Switzerland), 2021, Aug-18, Volume: 26, Issue:16

    Topics: Aminobutyrates; Animals; Biphenyl Compounds; Drug Combinations; Drug Interactions; Fibrosis; Humans; Male; Myocardial Infarction; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Valsartan; Ventricular Function, Left; Ventricular Remodeling

2021
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.
    Cardiovascular research, 2018, 08-01, Volume: 114, Issue:10

    Topics: Adaptation, Physiological; Angiotensin II; Animals; Blood Pressure; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Enzyme Activation; Heart Diseases; Hypertension; Male; Mice, Inbred C57BL; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; Signal Transduction; Time Factors; Ventricular Remodeling

2018
Resveratrol attenuates left ventricular remodeling in old rats with COPD induced by cigarette smoke exposure and LPS instillation.
    Canadian journal of physiology and pharmacology, 2013, Volume: 91, Issue:12

    Topics: Animals; Apoptosis; Emphysema; Lipopolysaccharides; Male; Malondialdehyde; Myocardium; Myocytes, Cardiac; Nicotiana; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Smoke; Smoking; Stilbenes; Superoxide Dismutase; Ventricular Function, Left; Ventricular Remodeling

2013
Inhibition of NOX/VPO1 pathway and inflammatory reaction by trimethoxystilbene in prevention of cardiovascular remodeling in hypoxia-induced pulmonary hypertensive rats.
    Journal of cardiovascular pharmacology, 2014, Volume: 63, Issue:6

    Topics: Animals; Hemeproteins; Hypertension, Pulmonary; Hypoxia; Inflammation; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Peroxidases; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes; Ventricular Remodeling

2014
Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats.
    Journal of physiology and biochemistry, 2014, Volume: 70, Issue:3

    Topics: Animals; Antioxidants; Cardiotonic Agents; Cardiotoxicity; Caspase 3; Doxorubicin; Fibrosis; Gene Expression; Glutathione; Heart; Heart Ventricles; Male; Rats; Rats, Wistar; Resveratrol; RNA, Messenger; Stilbenes; Superoxide Dismutase; Transforming Growth Factor beta1; Ventricular Remodeling

2014
Resveratrol treatment of mice with pressure-overload-induced heart failure improves diastolic function and cardiac energy metabolism.
    Circulation. Heart failure, 2015, Volume: 8, Issue:1

    Topics: Animals; Disease Models, Animal; Energy Metabolism; Heart Failure, Diastolic; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Resveratrol; Ribonucleotide Reductases; Stilbenes; Stroke Volume; Vasodilator Agents; Ventricular Function, Left; Ventricular Remodeling

2015
Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium is Associated with an Improved Cardiac Phenotype.
    Cardiovascular drugs and therapy, 2017, Volume: 31, Issue:1

    Topics: Animals; Antioxidant Response Elements; Antioxidants; Disease Models, Animal; Kruppel-Like Transcription Factors; Male; Myocardial Infarction; Myocardium; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; Phenotype; Rats, Sprague-Dawley; Resveratrol; RNA, Messenger; Stilbenes; Time Factors; Up-Regulation; Ventricular Remodeling

2017
Long-term low dose dietary resveratrol supplement reduces cardiovascular structural and functional deterioration in chronic heart failure in rats.
    Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:3

    Topics: Animals; Cardiotonic Agents; Chronic Disease; Collagen; Dietary Supplements; Disease Models, Animal; Drug Administration Schedule; Echocardiography; Fibrosis; Heart Failure; Male; Myocardial Contraction; Myocardium; Pulse Wave Analysis; Rats, Wistar; Resveratrol; Stilbenes; Stroke Volume; Time Factors; Vascular Stiffness; Ventricular Function, Left; Ventricular Remodeling

2017
Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats.
    Life sciences, 2008, Aug-29, Volume: 83, Issue:9-10

    Topics: Animals; Antioxidants; Atrial Natriuretic Factor; Collagen Type I; Echocardiography; Hemodynamics; Male; Mice; Myocardial Ischemia; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Transforming Growth Factor beta1; Ventricular Remodeling

2008
Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction.
    Cardiovascular drugs and therapy, 2008, Volume: 22, Issue:6

    Topics: Administration, Oral; Animals; Calcium Channels, L-Type; Cardiac Pacing, Artificial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; KATP Channels; Male; Myocardial Infarction; Patch-Clamp Techniques; Phytoalexins; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Resveratrol; Sesquiterpenes; Stilbenes; Survival Rate; Tachycardia, Ventricular; Telemetry; Terpenes; Time Factors; Ventricular Fibrillation; Ventricular Remodeling

2008
Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.
    Current pharmaceutical biotechnology, 2011, Mar-01, Volume: 12, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Desoxycorticosterone; Fibrosis; Heart; Heart Ventricles; Humans; Hypertension; Male; Mineralocorticoids; Rats; Rats, Wistar; Resveratrol; Sodium Chloride, Dietary; Stilbenes; Ventricular Remodeling

2011
Resveratrol protects left ventricle by increasing adenylate kinase and isocitrate dehydrogenase activities in rats with myocardial infarction.
    The Chinese journal of physiology, 2011, Dec-31, Volume: 54, Issue:6

    Topics: Adenylate Kinase; Animals; Antioxidants; Blotting, Western; Cardiotonic Agents; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Energy Metabolism; Enzyme Activation; Immunohistochemistry; Isocitrate Dehydrogenase; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Ventricular Remodeling

2011
Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Actins; Animals; Apoptosis; Blood Glucose; Body Weight; Calcium Signaling; Cell Count; Coculture Techniques; Diabetes Mellitus, Type 1; Endothelial Cells; Hemodynamics; HMGB1 Protein; Intracellular Space; Male; Myocardium; Myocytes, Cardiac; Rats; Rats, Wistar; Resveratrol; Stem Cells; Stilbenes; Ventricular Remodeling

2012
Longitudinal in vivo SPECT/CT imaging reveals morphological changes and cardiopulmonary apoptosis in a rodent model of pulmonary arterial hypertension.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Animals; Annexins; Apoptosis; Blood Pressure; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Heart Ventricles; Humans; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Myocardium; Perfusion; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Systole; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventricular Remodeling

2012
Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine*.
    Critical care medicine, 2012, Volume: 40, Issue:11

    Topics: Animals; Animals, Newborn; Chemokine CX3CL1; Disease Models, Animal; Electrocardiography; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Platelet Aggregation Inhibitors; Random Allocation; Rats; Resveratrol; Stilbenes; Ventricular Remodeling

2012
Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.
    The American journal of pathology, 2013, Volume: 182, Issue:3

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Apoptosis; Autophagy; Cells, Cultured; Densitometry; Energy Metabolism; Heart Failure; Heart Function Tests; Male; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirtuin 1; Stilbenes; Superoxide Dismutase; TOR Serine-Threonine Kinases; Vacuoles; Ventricular Remodeling

2013
Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 323, Issue:3

    Topics: Animals; Cardiotonic Agents; Echocardiography; Hemodynamics; Male; Myocardial Infarction; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Ventricular Remodeling

2007